A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response

por Vestermark, LW, Holtved, E, Dahlrot, R, Brimnes, MK, Svane, IM, Bastholt, L
Publicado 2008

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

por Mohammad, H., Madsen, K., Graumann, O., Loya, A.C., Jensen, N.V., Dahlrot, R.H.
Publicado 2021

Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective,...

por Mikic, N., Poulsen, F. R., Kristoffersen, K. B., Laursen, R. J., Guldberg, T. L., Skjøth-Rasmussen, J., Wong, E. T., Møller, S., Dahlrot, R. H., Sørensen, J. C. H., Korshøj, A. R.
Publicado 2021